Seeing Through LEMS: From Early Detection to Advanced Management (CME Webcast)

Activity Description and Purpose

This educational activity for neuro-ophthalmologists focuses on Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder affecting the neuromuscular junction, leading to muscle weakness, fatigue, and autonomic dysfunction. The program aims to enhance the understanding of LEMS among ophthalmologists, covering its pathophysiology, diagnostic criteria, and treatment options. Participants will learn to identify clinical features, implement appropriate diagnostic measures, and evaluate clinical trial data on treatments through interactive case studies and expert discussions. By the end of the activity, ophthalmologists will be better equipped to recognize LEMS, facilitate early diagnosis, and formulate and implement optimal treatment plans for this complex disorder.

Target Audience

This educational activity is intended for ophthalmologists.

Learning Objectives

After completing this activity, participants will be better able to:

  • Identify the appropriate diagnostic measures for Lambert-Eaton myasthenic syndrome
  • Evaluate clinical trial data on treatment for Lambert-Eaton myasthenic syndrome
  • Implement optimal therapeutic strategies for patients with Lambert-Eaton myasthenic syndrome
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
07/17/2024
Course expires: 
07/31/2025

Faculty

Andrew G. Lee, MD
Herb and Jean Lyman Centennial Chair in Ophthalmology
Department of Ophthalmology
Blanton Eye Institute
Professor of Ophthalmology, Neurology, and Neurosurgery
Academic Institute
Full Clinical Member
Research Institute
Houston Methodist
Weill Cornell Medical College
Houston, Texas

 

John J. Chen, MD, PhD

Professor of Ophthalmology and Neurology
Neuro-ophthalmology Fellowship Director
Mayo Clinic
Rochester, Minnesota

T. Aaron Judd, OD
Board-Certified Optometrist
Quigley Eye Specialists
Fort Myers, Florida

 

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.

Faculty

John J. Chen, MD, PhD, is a consultant for Amgen Inc and UCB SA.

T. Aaron Judd, OD, has no relevant commercial relationships to disclose.

Andrew G. Lee, MD, is a consultant for ​​​AstraZeneca and Bristol-Myers Squibb​​ Company; is an advisory board member of Stoke Therapeutics and Viridian Therapeutics, Inc; and is on the speakers bureau for Alexion Pharmaceuticals, Inc and Amgen Inc.

Peer Reviewer

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Planners, Managers, and Writers

MedEdicus planners and managers have no relevant commercial relationships to disclose.

Medical Writer: Robert M. Geist IV, MD, has no relevant commercial relationships to disclose.

Accreditation Statement

 MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

MedEdicus LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support

This continuing medical education activity is supported through an educational grant from Catalyst Pharmaceuticals, Inc.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the MedEdicus LLC or Catalyst Pharmaceuticals, Inc.

This CME activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 325

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.

Clicking Register/Take course indicates that you have reviewed the CME information for this activity.